Osteoarthritis Market
  • Published on 2023-04-27
    • Report Code: 1452
    • 170-350 pages

Osteoarthritis Market

Sample request

Osteoarthritis Market Size, Share, and Analysis, By Type (Hip Osteoarthritis, Knee Osteoarthritis, Foot & Ankle Osteoarthritis, Shoulder Osteoarthritis, Spinal Osteoarthritis), By Drug Type (Analgesics, Corticosteroids, Viscosupplementation agents, Nonsteroidal anti-inflammatory drugs {NSAIDS}), By Diagnosis (Imagining and Joint Fluid Analysis), By Route of Administration (Parenteral Route, Oral Route, Topical Route), By Treatment (Medication, Therapy, Surgery), By Distribution Channel (Hospitals Pharmacy, E-Commerce, Retail Pharmacy, Drug Store), By Purchasing Pattern (Prescription Drugs, Over-The-Counter Drugs) and Regional Forecasts, 2022-2032

Table Of Content

1 Executive Summary 
    1.1. Regional Market Share 
    1.2. Business Trends 
    1.3. Osteoarthritis Market: COVID-19 Outbreak 
    1.4. Regional Trends 
    1.5. Segmentation Snapshot 
2 Research Methodology 
    2.1. Research Objective 
    2.2. Research Approach 
    2.3. Data Sourcing and Methodology 
    2.4. Primary Research 
    2.5. Secondary Research 
           2.5.1.  Paid Sources
           2.5.2.  Public Sources
    2.6. Market Size Estimation and Data Triangulation 
3 Market Characteristics 
    3.1. Market Definition 
    3.2.   Osteoarthritis Market: COVID-19 Impact 
    3.3. Key Segmentations 
    3.4. Key Developments 
    3.5. Allied Industry Data 
4 Osteoarthritis Market – Industry Insights 
    4.1. Industry Segmentation 
    4.2. COVID-19 overview on world economy 
    4.3. Industry ecosystem Channel analysis 
    4.4. Innovation & Sustainability 
5 Macroeconomic Indicators 
6 Recent Developments 
7 Market Dynamics 
    7.1. Introduction 
    7.2. Growth Drivers 
    7.3. Market Opportunities 
    7.4. Market Restraints 
    7.5. Market Trends 
8 Risk Analysis 
9 Market Analysis 
    9.1. Porters Five Forces 
    9.2. PEST Analysis 
           9.2.1. Political
           9.2.2. Economic
           9.2.3. Social
           9.2.4. Technological
10 Osteoarthritis Market  
    10.1. Overview 
    10.2. Historical Analysis (2016-2020) 
           10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11   Osteoarthritis Market Size & Forecast 2022A-2032F 
    11.1. Overview 
    11.2. Key Findings 
    11.3. Market Segmentation 
           11.3.1. By Type 
                    11.3.1.1. Hip Osteoarthritis
                               11.3.1.1.1. By Value (USD Million) 2022-2032F
                               11.3.1.1.2. Market Share (%) 2022-2032F
                               11.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
                    11.3.1.2. Knee Osteoarthritis
                               11.3.1.2.1. By Value (USD Million) 2022-2032F
                               11.3.1.2.2. Market Share (%) 2022-2032F
                               11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
                    11.3.1.3. Foot & Ankle Osteoarthritis
                               11.3.1.3.1. By Value (USD Million) 2022-2032F
                               11.3.1.3.2. Market Share (%) 2022-2032F
                               11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
                    11.3.1.4. Shoulder Osteoarthritis
                               11.3.1.4.1. By Value (USD Million) 2022-2032F
                               11.3.1.4.2. Market Share (%) 2022-2032F
                               11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
                    11.3.1.5. Spinal Osteoarthritis
                               11.3.1.5.1. By Value (USD Million) 2022-2032F
                               11.3.1.5.2. Market Share (%) 2022-2032F
                               11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F
           11.3.2. By Drug Type 
                    11.3.2.1. Analgesics
                               11.3.2.1.1. By Value (USD Million) 2022-2032F
                               11.3.2.1.2. Market Share (%) 2022-2032F
                               11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
                    11.3.2.2. Corticosteroids
                               11.3.2.2.1. By Value (USD Million) 2022-2032F
                               11.3.2.2.2. Market Share (%) 2022-2032F
                               11.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
                    11.3.2.3. Viscosupplementation agents
                               11.3.2.3.1. By Value (USD Million) 2022-2032F
                               11.3.2.3.2. Market Share (%) 2022-2032F
                               11.3.2.3.3. Y-o-Y Growth (%) 2022-2032F
                    11.3.2.4. Nonsteroidal anti-inflammatory drugs {NSAIDS}
                               11.3.2.4.1. By Value (USD Million) 2022-2032F
                               11.3.2.4.2. Market Share (%) 2022-2032F
                               11.3.2.4.3. Y-o-Y Growth (%) 2022-2032F
           11.3.3. By Diagnosis 
                    11.3.3.1. Imagining
                               11.3.3.1.1. By Value (USD Million) 2022-2032F
                               11.3.3.1.2. Market Share (%) 2022-2032F
                               11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
                    11.3.3.2. Joint Fluid Analysis
                               11.3.3.2.1. By Value (USD Million) 2022-2032F
                               11.3.3.2.2. Market Share (%) 2022-2032F
                               11.3.3.2.3. Y-o-Y Growth (%) 2022-2032F
           11.3.4. By Route of Administration 
                    11.3.4.1. Parenteral Route
                               11.3.4.1.1. By Value (USD Million) 2022-2032F
                               11.3.4.1.2. Market Share (%) 2022-2032F
                               11.3.4.1.3. Y-o-Y Growth (%) 2022-2032F
                    11.3.4.2. Oral Route
                               11.3.4.2.1. By Value (USD Million) 2022-2032F
                               11.3.4.2.2. Market Share (%) 2022-2032F
                               11.3.4.2.3. Y-o-Y Growth (%) 2022-2032F
                    11.3.4.3. Topical Route
                               11.3.4.3.1. By Value (USD Million) 2022-2032F
                               11.3.4.3.2. Market Share (%) 2022-2032F
                               11.3.4.3.3. Y-o-Y Growth (%) 2022-2032F
           11.3.5. By Treatment 
                    11.3.5.1. Medication
                               11.3.5.1.1. By Value (USD Million) 2022-2032F
                               11.3.5.1.2. Market Share (%) 2022-2032F
                               11.3.5.1.3. Y-o-Y Growth (%) 2022-2032F
                    11.3.5.2. Therapy
                               11.3.5.2.1. By Value (USD Million) 2022-2032F
                               11.3.5.2.2. Market Share (%) 2022-2032F
                               11.3.5.2.3. Y-o-Y Growth (%) 2022-2032F
                    11.3.5.3. Surgery
                               11.3.5.3.1. By Value (USD Million) 2022-2032F
                               11.3.5.3.2. Market Share (%) 2022-2032F
                               11.3.5.3.3. Y-o-Y Growth (%) 2022-2032F
           11.3.6. By Distribution Channel 
                    11.3.6.1. Hospitals Pharmacy
                               11.3.6.1.1. By Value (USD Million) 2022-2032F
                               11.3.6.1.2. Market Share (%) 2022-2032F
                               11.3.6.1.3. Y-o-Y Growth (%) 2022-2032F
                    11.3.6.2. E-Commerce
                               11.3.6.2.1. By Value (USD Million) 2022-2032F
                               11.3.6.2.2. Market Share (%) 2022-2032F
                               11.3.6.2.3. Y-o-Y Growth (%) 2022-2032F
                    11.3.6.3. Retail Pharmacy
                               11.3.6.3.1. By Value (USD Million) 2022-2032F
                               11.3.6.3.2. Market Share (%) 2022-2032F
                               11.3.6.3.3. Y-o-Y Growth (%) 2022-2032F
                    11.3.6.4. Drug Store
                               11.3.6.4.1. By Value (USD Million) 2022-2032F
                               11.3.6.4.2. Market Share (%) 2022-2032F
                               11.3.6.4.3. Y-o-Y Growth (%) 2022-2032F
           11.3.7. By Purchasing Pattern
                    11.3.7.1. Prescription Drugs
                               11.3.7.1.1. By Value (USD Million) 2022-2032F
                               11.3.7.1.2. Market Share (%) 2022-2032F
                               11.3.7.1.3. Y-o-Y Growth (%) 2022-2032F
                    11.3.7.2. Over-The-Counter Drugs
                               11.3.7.2.1. By Value (USD Million) 2022-2032F
                               11.3.7.2.2. Market Share (%) 2022-2032F
                               11.3.7.2.3. Y-o-Y Growth (%) 2022-2032F
12 North America Osteoarthritis Market Size & Forecast 2022A-2032F 
    12.1. Overview 
    12.2. Key Findings 
    12.3. Market Segmentation 
           12.3.1. By Type
           12.3.2. By Drug Type
           12.3.3. By Diagnosis
           12.3.4. By Route of Administration
           12.3.5. By Treatment
           12.3.6. By Distribution Channel
           12.3.7. By Purchasing Pattern
    12.4. Country 
           12.4.1. United States
           12.4.2. Canada
13 Europe Osteoarthritis Market Size & Forecast 2022A-2032F 
    13.1. Overview 
    13.2. Key Findings 
    13.3. Market Segmentation 
           13.3.1. By Type
           13.3.2. By Drug Type
           13.3.3. By Diagnosis
           13.3.4. By Route of Administration
           13.3.5. By Treatment
           13.3.6. By Distribution Channel
           13.3.7. By Purchasing Pattern
    13.4. Country 
           13.4.1. Germany
           13.4.2. United Kingdom
           13.4.3. France
           13.4.4. Italy
           13.4.5. Spain
           13.4.6. Russia
           13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14 Asia Osteoarthritis Market Size & Forecast 2022A-2032F 
    14.1. Overview 
    14.2. Key Findings 
    14.3. Market Segmentation 
           14.3.1. By Type
           14.3.2. By Drug Type
           14.3.3. By Diagnosis
           14.3.4. By Route of Administration
           14.3.5. By Treatment
           14.3.6. By Distribution Channel
           14.3.7. By Purchasing Pattern
    14.4. By Country 
           14.4.1. India
           14.4.2. China
           14.4.3. South Korea
           14.4.4. Japan
           14.4.5. Rest of APAC
15 Middle East and Africa Osteoarthritis Market Size & Forecast 2022A-2032F 
    15.1. Overview 
    15.2. Key Findings 
    15.3. Market Segmentation 
           15.3.1. By Type
           15.3.2. By Drug Type
           15.3.3. By Diagnosis
           15.3.4. By Route of Administration
           15.3.5. By Treatment
           15.3.6. By Distribution Channel
           15.3.7. By Purchasing Pattern
    15.4. Country 
           15.4.1. Israel
           15.4.2. GCC
           15.4.3. North Africa
           15.4.4. South Africa
           15.4.5. Rest of Middle East and Africa
16 Latin America Osteoarthritis Market Size & Forecast 2022A-2032F 
    16.1. Overview 
    16.2. Key Findings 
    16.3. Market Segmentation 
           16.3.1. By Type
           16.3.2. By Drug Type
           16.3.3. By Diagnosis
           16.3.4. By Route of Administration
           16.3.5. By Treatment
           16.3.6. By Distribution Channel
           16.3.7. By Purchasing Pattern
    16.4. Country 
           16.4.1. Mexico
           16.4.2. Brazil
           16.4.3. Rest of Latin America
17 Competitive Landscape 
    17.1. Company market share, 2021 
    17.2. Key player overview 
    17.3. Key stakeholders 
18 Company Profiles 
    18.1. Pfizer Inc 
           18.1.1. Company Overview
           18.1.2. Financial Overview
           18.1.3. Key Product; Analysis
           18.1.4. Company Assessment
                    18.1.4.1. Product Portfolio
                    18.1.4.2. Key Clients
                    18.1.4.3. Market Share
                    18.1.4.4. Recent News & Development (Last 3 Yrs.)
                    18.1.4.5. Executive Team
    18.2. Abbott 
    18.3. Novartis AG 
    18.4. Eli Lilly and Company 
    18.5. Bayer AG 
    18.6. Johnson & Johnson 
    18.7. ABIOGEN PHARMA S.p.A 
    18.8. Merck Sharp & Dohme Corp. 
    18.9. Apotex Inc. 
    18.10. TissueGene Inc. 
    18.11. Ampio Pharmaceuticals Inc. 
    18.12. Mylan N.V. 
    18.13. Tolmar Pharmaceuticals, Inc.  
    18.14. Other Prominent Players 
19 Appendix 
20 Consultant Recommendation 

Research Methodology

Primary Research

  • Fatpos Global’s dedicated primary research wing comprises a team of analysts adept at conducting and engaging in detailed primary interviews with key industry stakeholders across the entire value chain.
  • The primary research comprises formulation of a detailed discussion guides composed of questions pertaining to various data points essential developing an in-depth report.
  • The subsequent stages development of an exhaustive market participants, key opinion leaders, industry experts and executives, among others.
  • Manufacturers, distributors & suppliers, key End Users, industry experts, opinion leaders, and industry association members, among others compose the sample for the research study

Supply Side

  • R&D technicians and technologists
  • Procurement Managers
  • Physician If s/Specialist
  • Research Professors
  • Healthcare Providers
  • Consumers
  • Distributors & Channels
  • Service Provide

Demand Side

  • CEOs
  • Vice presidents
  • Marketing directors
  • RProduct Managers
  • Regional Sales and
  • Marketing Managers
  • Business Development
  • Plant Manage

Research Framework

    Objective of Research

  • The objective of the research is to provide a 360 holistic view on the market and bringing the insights that can help stakeholders identify the opportunities as well as challenges.
  • We have provided the market size in terms of value and volume of market with segmentation and offers in-depth commentary and accurate quantitative insights.
  • The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

    Primary Research

  • Fatpos Global’s dedicated primary research wing comprises a team of analyst adept at conducting and engaging in detailed primary interviews with key industry stakeholders across the entire value chain.
  • The primary research comprises formulation of a detailed discussion guides composed of questions pertaining to various data points essential developing an in-depth report.
  • The subsequent stages development of an exhaustive market participants, key opinion leaders, industry experts and executives, among others.
  • Manufacturers, distributors & suppliers, key End Users, industry experts, opinion leaders, and industry association members, among others compose the sample for the research study
  • Analysts compile the whole data from demand and supply-side perceptions

    Secondary Research

  • Data is gathered from various secondary databases.
  • Diligently tracking the secondary sources for closely monitoring the market trends and insights.
  • Analysts compile the whole data from demand and supply-side perceptions for the better outputs.

Data Sources

    Research Approach

  • Demand Estimation of each product across countries/regions summed from the total market
  • Variable analysis for demand forecasting
  • Demand estimation via analysing paid database, company financials either via annual report or database
  • Primary interviews for data revalidation and insights collection.
  • Used extensively for new product forecasting or analysing penetration level
  • Tool used invoices product flow & penetration models
  • Use of regression multi variate analysis for forecasting
  • Involve extensive use of paid and public database
  • Primary interviews & vendor-based primary research for variable impact analysis

Bottom-Up Approach

Top-Down Approach

To request a free sample copy of this report, please complete the form below.

Purchase Report

Select your license

$3199

Buy Now Add to cart

Compare all license features

Note: In case you require a hard copy, there will be an additional charge of $500.

Sample request

Read all reports

Sciatica Treatment Market
Sciatica Treatment Market

Sciatica Treatment Market Size, Share, and Analysis, By Type (Chronic Sciatica, Acute Sciatica), By Drug Class (Steroids, Non-Steroidal Anti-Inflammatory Drugs, Antidepressants, and Others), By Distribution Channel (Retail and Specialty Pharmacies, Hospital Pharmacies, Online Providers), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

$3199

Second-Hand Products Market
Second-Hand Products Market

Second-Hand Products Market Size, Share, and Analysis, By Product Type (Sporting Goods, Electronics, Clothing, Vehicles, Furniture, and Others), By End Use (Individual, Commercial), By Brand Type (Luxury Brands, Non-Luxury Brands), By Distribution Channel (Online, Offline) and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034 

$3199

Peripheral Intravenous Catheters Market
Peripheral Intravenous Catheters Market

Peripheral Intravenous Catheters Market Size, Share, and Analysis, By Product Type (Short PIVC, Integrated/Closed PIVC), By Technology (Conventional PIVC, Safety PIVC), By End User (Hospitals, Ambulatory Surgical Centres, and Other End Users) and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034

$3199

Connected Energy Market
Connected Energy Market

Connected Energy Market Size, Share, and Analysis, By Type (Smart Solar, Smart Grid, Digital Oilfields, and Home Energy Management Systems), By Application (Residential, Commercial, and Industrial), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

$3199

Renewable Energy Technology Market
Renewable Energy Technology Market

Renewable Energy Technology Market Size, Share, and Analysis, By Type (Hydroelectric Power, Wind Power, Solar Power, Geothermal Energy, and Bioenergy), By Application (Commercial, Residential, and Industrial), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

$3199

Poultry Market
Poultry Market

Poultry Market Size, Share, and Analysis, By Type (Chicken, Turkey, Duck, and Others), By Product Type (Fresh, Frozen, Ready-To-Cook, Ready-To-Eat, Others), By Nature (Organic, Conventional), By Distribution Channel (Supermarkets/Hypermarkets, Convenience Stores, Food Services, E-Commerce, and Others), and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034

$3199

LNG and LPG Market
LNG and LPG Market

LNG and LPG Market Size, Share, and Analysis, By Type (Liquefied Petroleum Gas (LPG) and Liquefied Natural Gas (LNG)), By Application (Residential Heating, Transportation, Industrial, and Power Generation), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

$3199

LNG Carrier Market
LNG Carrier Market

LNG Carrier Market Size, Share, and Analysis, By Type (Membrane Type and Moss Type), By Capacity (Above 160,000 m3, 120,000-160,000 m3, and Under 120,000 m3), By Application (International Transportation and Domestic Transportation), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

$3199

LPG Carriers Market
LPG Carriers Market

LPG Carriers Market Size, Share, and Analysis, By Type (Total Cooling (Above 50000m³), Semi-Cold and Semi-Pressed (5000m³-50000m³), Full Pressure Type (Below 5000m³)), By Carrier Size (Small Gas Carriers (SGC), Medium Gas Carriers (MGC), Large Gas Carriers (LGC), and Very Large Gas Carriers (VLGC)), By Application (Leasing Company, and Shipowner), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

$3199

Ocean Freight Market
Ocean Freight Market

Ocean Freight Market Size, Share, and Analysis, By Type (Less than Container Load (LCL), Full Container Load (FCL), and Breakbulk Cargo), By Carrier Type (Tankers, Bulk Carriers, Containers, and Others), By Application (Manufacturing, Electronics, Agricultural, Automotive, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

$3199

Our Clients

We have been working with some Fortune 500+ clients

we use cookie for improve your experience

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy . By continuing to use this site, or closing this box, you consent to our use of cookies. More info .